Last reviewed · How we verify
Glycotope GmbH — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
2 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 1
- Reproductive Health · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
- Ain Shams Maternity Hospital · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
- Azienda USL Modena · 1 shared drug class
- Bezmialem Vakif University · 1 shared drug class
- Brenda Cooper, MD · 1 shared drug class
- Bristol-Myers Squibb · 1 shared drug class
- AGUNCO Obstetrics and Gynecology Centre · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Glycotope GmbH:
- Glycotope GmbH pipeline updates — RSS
- Glycotope GmbH pipeline updates — Atom
- Glycotope GmbH pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Glycotope GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/glycotope-gmbh. Accessed 2026-06-10.